Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R G Larkins

Showing results (11-20 of 135) with videos related to

Pageof 14
Sort By:
Diabetologia|October 1, 1971
Plasma growth hormone in the New Zealand obese mouseR G Larkins
The Medical Journal of Australia|May 4, 1987
The use of oral hypoglycaemic agents in the treatment of diabetes mellitusR G Larkins
The Medical Journal of Australia|December 9, 1985
To screen or not to screen--the diabetic dilemmaR G Larkins
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|January 1, 1997
Prolactin secreting pituitary tumours with marked visual field impairment should be treated by bromocriptineR G Larkins
Diabetes|April 1, 1973
Defective insulin secretory response to glucose in the New Zealand obese mouse. Improvement with restricted dietR G Larkins
Endocrinology|November 1, 1973
Defective insulin secretion in the N.Z.O. mouse: in vitro studiesR G Larkins
The Medical Journal of Australia|March 2, 1987
The management of patients with poorly-controlled non-insulin dependent diabetesR G Larkins
FEBS Letters|December 2, 1985
Presence of membrane-associated phosphatidate phosphohydrolase activity in cultured islets and its stimulation by glucoseM Dunlop, R G Larkins
Diabetes|March 1, 1981
Decreased stimulated glucose oxidation and iodination by polymorphonuclear leukocytes from insulin-treated diabetic subjectsR Qvist, R G Larkins
Diabetes|July 1, 1983
Diminished production of thromboxane B2 and prostaglandin E by stimulated polymorphonuclear leukocytes from insulin-treated diabetic subjectsR Qvist, R G Larkins
Pageof 14

Showing results (11-20 of 135) with videos related to

Sort By:
Pageof 14
Diabetologia|October 1, 1971
Plasma growth hormone in the New Zealand obese mouseR G Larkins
The Medical Journal of Australia|May 4, 1987
The use of oral hypoglycaemic agents in the treatment of diabetes mellitusR G Larkins
The Medical Journal of Australia|December 9, 1985
To screen or not to screen--the diabetic dilemmaR G Larkins
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|January 1, 1997
Prolactin secreting pituitary tumours with marked visual field impairment should be treated by bromocriptineR G Larkins
Diabetes|April 1, 1973
Defective insulin secretory response to glucose in the New Zealand obese mouse. Improvement with restricted dietR G Larkins
Endocrinology|November 1, 1973
Defective insulin secretion in the N.Z.O. mouse: in vitro studiesR G Larkins
The Medical Journal of Australia|March 2, 1987
The management of patients with poorly-controlled non-insulin dependent diabetesR G Larkins
FEBS Letters|December 2, 1985
Presence of membrane-associated phosphatidate phosphohydrolase activity in cultured islets and its stimulation by glucoseM Dunlop, R G Larkins
Diabetes|March 1, 1981
Decreased stimulated glucose oxidation and iodination by polymorphonuclear leukocytes from insulin-treated diabetic subjectsR Qvist, R G Larkins
Diabetes|July 1, 1983
Diminished production of thromboxane B2 and prostaglandin E by stimulated polymorphonuclear leukocytes from insulin-treated diabetic subjectsR Qvist, R G Larkins
Pageof 14